Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-31 Sale | 2022-11-02 8:36 pm | Aura Biosciences Inc. | AURA | De Rosch Mark Chief Operating Officer | 1,115 | $12.46 | $13,890 | 16,385 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-05-23 4:12 pm | N/A 2034-11-07 | CervoMed Inc. | CRVO | De Rosch Mark EVP, RA and GA and PgM | 0 | $0 | 59,000 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 6:36 pm | N/A 2033-01-18 | Aura Biosciences Inc. | AURA | De Rosch Mark Chief Operating Officer | 107,250 | $0 | 123,635 (Direct) | View |
| 2021-10-28 Option Award | 2021-10-29 7:28 pm | N/A 2031-10-27 | Aura Biosciences Inc. | AURA | De Rosch Mark Chief Operating Officer | 92,500 | $0 | 92,500 (Direct) | View |
Ownership | 2021-10-28 8:23 pm | N/A 2031-03-23 | Aura Biosciences Inc. | AURA | De Rosch Mark Chief Operating Officer | 0 | $0 | 182,167 (Direct) | View |